ZYBERNO
Stock Report
Updated Sep 1, 2026

UNITED HEALTH PRODUCTS, INC. (UEEC)

Healthcare • OTC

$0.04

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
0.0/100
POOR BUSINESS
UNITED HEALTH PRODUCTS, INC. (UEEC) scores 0/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-281.4%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

UNITED HEALTH PRODUCTS, INC. (UEEC) stock report — Zyberno Score 0/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.04
Market Cap:$11.09M

Valuation Multiples (1)

Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$12.45M

Price Action & Momentum (3)

Momentum Percentile:11 / 100
% of 52-Week High:35.3%
B. Profitability Assessment

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$999.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:100.0%
Latest Earnings Filed:2026-08-14
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.02x
Quick Ratio:0.02x
Cash Ratio:0.00x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-13.58x
Times Interest Earned:-13.58

Capital Structure (4)

Working Capital:-4,123,570.00
Cash And Cash Equivalents:0.00
Long Term Debt:$0.00
Net Debt:$1.36M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$930.33K

Bottom Line Performance (3)

-$1.42M
Income Before Tax:$0.00
Ebitda Ttm:-926,283.00

Operating Expenses (5)

Operating Expenses:930,333.00
R And D Expense:89,047.00
Sga Expense:841,286.00
Income Tax Expense:$0.00
Interest Expense:166,037.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$247.99K
Current Assets:$64.66K
Ppe Net:0.00
Goodwill:0.00
Intangible Assets:$22.28K

Liability Structure (4)

Total Liabilities:4,690,801.00
Current Liabilities:4,188,234.00
Long Term Debt:$0.00
Short Term Debt:$1.36M

Equity & Capital (3)

Equity:-$4.44M
Retained Earnings:-$82.08M
Common Stock:300,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:1,355,199.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

-$997.31K$0.00

Investment Activities (1)

Investing Cash Flow:$0.00

Financing Activities (3)

Financing Cash Flow:$20.12K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:395,425.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$19.14K

Non-Cash Items (1)

Depreciation Amortization Ttm:4,050.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (2)

$0.00
Earnings Per Share Ttm:-$0.01

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$0.00

Book Value & Capital (2)

Book Value Per Share:-$0.02
Cash Per Share:-999.00

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:10.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:UEEC
Company Name:UNITED HEALTH PRODUCTS, INC.
Sector:Healthcare
Industry:Medical Devices
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:261.59M
Shares Outstanding Basic:261.59M
Shares Outstanding Diluted:260.04M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 13:13:01 UTC
Data Timestamp:2026-08-21T07:51:26.502869
Scroll to Top